Rohto Pharmaceutical Dominates Japan Eye Care Market, According to Euromonitor Report Now Available at MarketPubloshers.com
25 Nov 2016 • by Natalie Aster
LONDON – As of 2014, current value growth of the Japanese eye care marketplace is estimated to be 4% thanks to significant growth (11%) that has taken place in the allergy eye care segment. Growth of the segment was caused by pollen in spring. Still the market is dominated by the standard eye care segment which holds a share of 87% of the total sales in terms of value. This segment has also showed 3% increase this year thanks to hybrid products that are expensive.
Rohto Pharmaceutical did not leave its position of the market leader in 2016. It holds a share of 42% of value sales, up by 2% from 2015.
Manufacturers have a number of concerns, and shift from eye drops to such products as disposable hot steam eye masks among young people is one of major ones.
To retain younger consumers, manufacturers take certain steps like the launch of an advertising campaign with a famous actor.
The Japanese eye care marketplace is set to showcase a 1% CAGR at constant 2016 prices in the offing. Its sales are forecast to total JPY 81 billion in 2021. Pollen levels will continue to have large impact on the eye care market in the coming years.
New research report “Eye Care in Japan” prepared by Euromonitor International Ltd. offers an up-close look at the Japanese eye care marketplace. The study delves deep into the competitive situation. It profiles top companies like the ones mentioned above.
The report throws light on the Japanese consumer health industry. The research study focuses on trends and developments in this space. It discloses valuable market data, as well. Five-year forecasts for this marketplace are contained in the research report, as well.
More new studies by our partner are available at Euromonitor page.
NB! If you want to buy more than one report of this publisher, read information about its discount scheme.